Gelteq Limited Ordinary Shares (GELS) is a publicly traded Healthcare sector company. As of May 21, 2026, GELS trades at $0.46 with a market cap of $4.34M and a P/E ratio of 0.00. GELS moved +27.74% today. Year to date, GELS is -43.11%; over the trailing twelve months it is -73.39%. Its 52-week range spans $0.39 to $5.50. Rallies surfaces GELS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Gelteq Names Healthy Extracts Exclusive U.S. Partner to Cut Costs and Tap $730B Market: Gelteq expanded its February partnership with Healthy Extracts, naming them exclusive North American partner for manufacturing, storage, fulfillment and shipping of its white-label gel-pack delivery products. The collaboration is expected to cut Gelteq’s fulfillment costs and boost higher-margin gel-pack sales in the $730 billion health and beauty market.
| Metric | Value |
|---|---|
| Price | $0.46 |
| Market Cap | $4.34M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.50 |
| 52-Week Low | $0.39 |
| Volume | 1.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
GELS analyst coverage data. Average price target: $0.00.